Alpha Tau Medical Future Growth
Future criteria checks 2/6
Alpha Tau Medical is forecast to grow revenue at 58% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Medical Equipment earnings growth | 17.6% |
| Revenue growth rate | 58.0% |
| Future return on equity | -10.9% |
| Analyst coverage | Low |
| Last updated | 20 Aug 2024 |
Recent future growth updates
Recent updates
Alpha Tau Medical (NASDAQ:DRTS) Has Debt But No Earnings; Should You Worry?
May 25
Alpha Tau Medical (NASDAQ:DRTS) Is In A Good Position To Deliver On Growth Plans
Nov 08Alpha Tau director gives up board seat to take up chief commercial officer role
Sep 02Alpha Tau Medical GAAP EPS of -$0.03
Aug 25Alpha Tau: Treating Cancer With Precision Alpha Radiation
Apr 12Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 20 | N/A | N/A | 13 | 3 |
| 12/31/2025 | 1 | N/A | N/A | -14 | 4 |
| 12/31/2024 | N/A | N/A | N/A | -26 | 4 |
| 6/30/2024 | N/A | -28 | -27 | -21 | N/A |
| 3/31/2024 | N/A | -29 | N/A | N/A | N/A |
| 12/31/2023 | N/A | -29 | -24 | -18 | N/A |
| 9/30/2023 | N/A | -25 | N/A | N/A | N/A |
| 6/30/2023 | N/A | -23 | -19 | -18 | N/A |
| 3/31/2023 | N/A | -16 | N/A | N/A | N/A |
| 12/31/2022 | N/A | -34 | -25 | -24 | N/A |
| 9/30/2022 | N/A | -34 | N/A | N/A | N/A |
| 6/30/2022 | N/A | -36 | -24 | -22 | N/A |
| 3/31/2022 | N/A | -41 | -18 | -15 | N/A |
| 12/31/2021 | N/A | -27 | -15 | -12 | N/A |
| 9/30/2021 | N/A | -26 | N/A | N/A | N/A |
| 6/30/2021 | N/A | -24 | -13 | -9 | N/A |
| 3/31/2021 | N/A | -19 | -12 | -9 | N/A |
| 12/31/2020 | N/A | -9 | -11 | -7 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if DRTS's forecast earnings growth is above the savings rate (2.5%).
Earnings vs Market: Insufficient data to determine if DRTS's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if DRTS's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: DRTS's revenue (58% per year) is forecast to grow faster than the US market (8.7% per year).
High Growth Revenue: DRTS's revenue (58% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: DRTS is forecast to be unprofitable in 3 years.